Editorial: Management of Sjögren's Syndrome
Front Med (Lausanne)
.
2022 Jan 13:8:836182.
doi: 10.3389/fmed.2021.836182.
eCollection 2021.
Authors
Alessia Alunno
1
,
Clio P Mavragani
2
,
Francesco Carubbi
1
3
Affiliations
1
Internal Medicine and Nephrology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
2
Department of Physiology and Joint Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
3
Department of Medicine, ASL1 Avezzano Sulmona L'Aquila, L'Aquila, Italy.
PMID:
35096918
PMCID:
PMC8792928
DOI:
10.3389/fmed.2021.836182
No abstract available
Keywords:
COVID-19; Sjögren's syndrome; biologic therapies; biomarkers; therapy; ultrasonography.
Publication types
Editorial